Siemens' syngo TrueD is designed for oncology, supporting PET/CT, SPECT/CT as well as CT or MR fused with PET or SPECT. The syngo TrueD was de-signed to allow physicians to compare patient scans from different time points (such as pre- and post-therapy) and provide advanced image analysis and comparison.
May 2008
June 19, 2025 — Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research ...
June 19, 2025 
May 5, 2025 — GE HealthCare recently announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance ...
May 06, 2025 
April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...
April 17, 2025 
April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...
April 10, 2025 
Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...
February 05, 2025 
Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...
January 27, 2025 
Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...
January 14, 2025 
Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration ...
December 18, 2024 
Dec. 2, 2024 — GE HealthCare has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing ...
December 05, 2024 
Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of ...
August 29, 2024